Ep. 40: The Triple Threat for Medtech: Inflation, Labor, and Supply Chain
Today the MedteXperts are joined by Scott Centea from AngioDyanmics. Scott entered AngioDynamics in 2005 as a sales representative serving the Carolinas. He served in a variety of positions, culminating in his most recent promotion to Sr. Vice President/General Manager of Endovascular Therapies and Peripheral Artery Disease. He continues to play a pivotal role in steering the company through an intentional transformation with an emphasis on his Endovascular Technologies business. His strategic insights and commitment to innovation have been instrumental in accelerating AngioDynamics' growth and expanding its market presence in these focused areas. Under his leadership, the company has solidified its position as a global leader in minimally invasive medical devices and technologies, helping providers advance care and wellness through innovation. Listen in to learn more about his insights and don't forget to subscribe!